LHA675
LHA675 is a fluorescent probe for early detection of ferroptosis. LHA675 mimics polyunsaturated lipids via a 4-phenyl-3-methylbut-2-enyl group to specifically detect highly oxidative radicals associated with ferroptosis, and releases a fluorophore after the reaction. LHA675 has excitation and emission wavelengths of 647 nm and 663-738 nm, respectively. LHA675 enables wash-free labeling of ferroptosis in living cells; the generated fluorophore localizes to mitochondria and emits deep red fluorescence. LHA675 can be used in studies related to the early detection of ferroptosis.
For research use only. We do not sell to patients.
- CAS No.: 3121511-18-7
- Formula: C41H52N2Si
- Molecular Weight:600.95
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Operating Instructions
(The following is a recommended experimental protocol for guidance only, and adjustments are required based on your specific needs)
1. Stock Solution Preparation
1.1 Solvent: For most dyes, organic solvents are commonly used for dissolution, such as anhydrous DMSO.
1.2 Concentration Recommendation: It is recommended to prepare a high-concentration stock solution at 1-10 mM.
2. Working Solution Preparation
2.1 Diluent: Phosphate buffer (50 mM, pH = 7.4) containing 10% MeCN.
2.2 Working Concentration: 5 μM.
2.3 Notes: The concentration of the working solution can be adjusted as needed; it must be prepared and used immediately.
3. Staining Procedure
3.1 Sample Type: Adherent cells (HeLa cells, HT22 cells)[1]
3.1.1 Adherent cells: No trypsin digestion is required for wash-free imaging.
3.2 Incubation Conditions: Incubate with 5 μM LHA675 for 10 min; excitation wavelength λex = 647 nm, emission wavelength λem = 663-738 nm.
3.3 Washing Step: No washing step is required for wash-free imaging.
4. Control Setup
4.1 Positive Control: Cells treated with ferroptosis inducers, including Erastin (HY-15763) (10 μM, 8 h), RSL3 (HY-100218A) (2 μM, 8 h), FIN56 (HY-103087) (5 μM, 10 h).
4.2 Negative Control: Cells pretreated with the ferroptosis inhibitor Ferrostatin-1 (HY-100579) (2 μM, 8 h pretreatment), followed by treatment with Erastin (10 μM, 8 h).
4.3 Blank Control: Untreated cells.
5. Detection and Analysis
5.1 Instrument: Confocal microscope.
5.1.1 Excitation/Emission Wavelengths: λex = 647 nm, λem = 663-738 nm.
5.2 Result Analysis:
5.2.1 Changes in Fluorescence Intensity: After reaction with oxidative free radicals (ROO·, RO·, HO·, ONOO−), fluorescence is significantly turned on (up to 360-fold); fluorescence intensity increases in a dose-dependent manner with the concentration of ferroptosis inducers; the fluorescent signal appears earlier during ferroptosis compared to the gold standard probe.
5.2.2 Fluorescence Localization: The generated fluorophore localizes to mitochondria.
5.2.3 Color Change: The probe emits deep red fluorescence upon activation.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3121511-18-7
-
Molecular Weight 600.95
-
Formula C41H52N2Si
-
SMILES
C/C(CC1=CC=CC=C1)=C\CC2(C3=CC=CC=C3)C4=C([Si](C)(C)C5=C2C=CC(CN(CC)CC)=C5)C=C(N(CC)CC)C=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)